The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...

THE German-Philippine Chamber of Commerce and Industry (GPCCI), in partnership with the German Embassy-Manila and Boehringer Ingelheim Philippines, convened a multi-stakeholder roundtable to address ...

Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 ...

Respiratory vaccines specialist Vicebio Ltd. is to be acquired by Sanofi SA in a $1.6 billion deal, of which $1.15 billion will be paid up front. The acquisition rests on an ongoing phase I trial of ...

The advanced heart failure market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical companies such as ...

Mainz, 22 July 2025. Boehringer Ingelheim Stiftung commits 7 million euros to support the EMBL Imaging Centre in Heidelberg. Boehringer Ingelheim Stiftung, Dr Friederike Keggenhoff, Officer, Web: ...

Lupin is releasing Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, which are the generic of Boehringer ...

Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...

The startup behind Chicago's more than $1 billion quantum computing deal said operations are expected to start in three years ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline ...